10 Stocks Analysts Downgraded On Tuesday

Stocks began the week with a sell-off. The S&P 500 fell 1.9% on Monday to 7,416.59. The pressure comes from interest rates. The Federal Reserve has raised them, and traders expect it to keep going.

The latest inflation report set the tone. The Bureau of Labor Statistics said consumer prices rose 0.4% in October, above the 0.3% economists expected, though below September’s 0.6% gain. Core prices, which leave out food and energy, rose 0.3% against a 0.2% forecast. Energy prices rose 0.7% in the month, food 0.5% and housing 0.3%.

Treasury yields jumped after the November 10 release. The 5-year yield rose 10 basis points to 4.75%, the 10-year rose 7 basis points to 4.93%, and the 30-year rose 3 basis points to 5.29%. Bets on a quarter-point rate hike in December stood at 84% that day, and bets on a half-point hike rose from 0% to 15%. Readers looking for cheaper names in a market like this can find more in our list of affordable stocks that Wall Street analysts like.

Goldman Strategists See a Reset in Tech Valuations

Not everyone is bearish. Peter Oppenheimer, who leads Goldman Sachs’ strategy team, and his colleagues forecast that the S&P 500 will climb 14% over the next 12 months to 8,700 points, even though the index is already up 11% in 2026. In a note reported on November 13, the call followed a 9% drop in the Nasdaq 100 from its early October high, driven by worries about the AI buildout.

The Goldman team says the biggest technology companies now trade well below their historical valuations, and it calls the group relatively defensive. It warns that those companies have turned cash-flow negative, though measures such as net debt to equity remain healthy. For stocks that analysts say have been sold too hard, see our list of oversold AI stocks where analysts see big upside.

The team expects earnings growth for S&P 500 companies to slow to 11% in 2027 from 36% in 2026, and growth for the Stoxx Europe 600 to slow to 7% from 18%. It is overweight US and Japanese stocks and underweight European ones, citing government debt issues and a heavy political calendar. It also favors industries that typically benefit from lower bond yields, easing inflation and falling oil prices. With growth slowing, Goldman expects investors to pay a premium for companies that can keep expanding quickly, and it sees opportunity in long-duration growth companies.

10 Stocks Analysts Downgraded On Tuesday

Photo by Arturo Añez on Unsplash

Our Methodology

To compile this list, we reviewed analyst rating downgrades announced on Tuesday, November 17, 2026. We have ranked these stocks in ascending order of their average upside potential, as of November 17.

At Insider Monkey, we are obsessed with what hedge funds do. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter strategy selects 14 small-cap and large-cap stocks every quarter and has returned 612% since May 2014, beating its benchmark by 375 percentage points (see more details here).

10 Stocks Analysts Downgraded On Tuesday

10. PepsiCo (NASDAQ:PEP)

Average Upside Potential: -1%

Bernstein cut PepsiCo to Underperform from Market Perform on November 17 and lowered its price target to $128 from $131. The firm expects the company to miss earnings per share expectations over the next 12 months because of weak results in North America, and it expects the stock’s multiple to shrink as investors accept that the company’s growth plan needs heavy catch-up spending.

PepsiCo makes and sells beverages, snacks and packaged foods, and Bernstein’s concerns sit in its two North American units. It expects Frito-Lay North America volumes to fall in 2027 as price investments lap and consumers keep buying fewer potato and tortilla chips. It also expects PepsiCo Beverages North America volumes to fall, with margins squeezed by inflation, higher advertising spending and the end of tariff benefits. Bernstein thinks productivity savings will not cover that gap. Bernstein expects international operations to offset part of the pressure but leave little room for error.

Bernstein also expects PepsiCo to keep losing market share as shoppers split between value and premium products, with limited pricing power. For the income side of the story, see our piece on whether PepsiCo’s dividend can hold up until a turnaround arrives.

9. Rapid Micro Biosystems (NASDAQ:RPID)

Average Upside Potential: 1%

Roth/MKM downgraded Rapid Micro Biosystems to Neutral from Buy on November 17 and lowered its price target to $0.75 from $3.00. The new target matches the price Merck KGaA, Darmstadt, Germany, agreed to pay in cash for each share, and the deal is expected to close in December 2026. A target set at the offer price leaves bulls with little to argue about, since the stock is now tied to the buyout.

Rapid Micro Biosystems sells automated systems that pharmaceutical manufacturers use to test products for microbial contamination. The business has been growing but has not yet reached profitability. Revenue rose 20.78% over the past 12 months, and revenue has grown 15.88% a year over the past five years. Operating margin over the past 12 months was -131.03%, which shows how far the company still is from covering its costs.

The deal builds on an existing partnership with MilliporeSigma, which covers distribution of the Growth Direct system, possible consumables sourcing benefits and joint development. Roth/MKM downgraded the stock because the buyout price now defines what shareholders can expect from it.

8. Stanley Black & Decker (NYSE:SWK)

Average Upside Potential: 4%

Mizuho downgraded Stanley Black & Decker to Neutral from Outperform on November 17 while raising its price target to $120 from $105. The firm said the stock’s year-to-date gain of about 54% left it well ahead of the S&P 500 and its building products index, and it said the call was about valuation, not execution. Mizuho praised its commercial initiatives, innovation and gross margin.

Stanley Black & Decker makes power tools, hand tools and related accessories, and it also sells electronic security and mechanical access products. Mizuho’s worries are about what comes next. Net tariff refunds are rolling off, the company is carrying pulled-forward investment, inflation is building, rates are high and pricing power has weakened. The firm sees 2027 adjusted earnings per share of roughly $6.25 to $6.85, which is modest growth.

Mizuho raised its 2026 earnings estimate to $6.09 from $5.56 and its 2027 estimate to $6.40 from $6.22. Jefferies has a more positive view and raised its price target to $135 from $109 while keeping a Buy rating, saying the company’s strategy worked even before the tariff refunds arrived. Readers weighing the bulls against Mizuho can read our analysis of whether a narrower portfolio improves returns.

7. Tyson Foods (NYSE:TSN)

Average Upside Potential: 4%

JPMorgan analyst Thomas Palmer downgraded Tyson Foods to Neutral from Overweight on November 17 and raised his price target to $65 from $63. Palmer said the stock had risen 9% on the day after the company reported fourth-quarter fiscal 2026 results and had gained 23% over two months. That was the strongest move among the companies JPMorgan covers. The firm had upgraded Tyson in September, when the shares traded at book value.

Tyson processes beef, pork and chicken and sells prepared foods. It had cut its fiscal 2026 outlook twice as processing margins weakened in beef and pork and chicken prices softened while feed costs rose. Its new fiscal 2027 outlook points to stabilizing trends in chicken and improving trends in beef after historically weak years. The outlook came with stronger cash flow and a higher dividend. Palmer said JPMorgan is encouraged by that, but he thinks the share price recovery now reflects the improvement in the underlying business.

The shares trade at 13.76 times forward earnings. How beef weakness put the recovery story to a test is the subject of an earlier piece from us.

6. IDACORP (NYSE:IDA)

Average Upside Potential: 9%

Jefferies analyst Julien Dumoulin-Smith downgraded IDACORP to Hold from Buy on November 17 and raised the price target to $163 from $155. The firm’s view is that the utility’s fundamentals are adequately reflected in the current valuation. It said IDACORP trades at a double-digit premium to peers and that near-term positive catalysts are largely known.

IDACORP is a holding company whose utility generates, transmits, distributes and sells electric energy. Jefferies likes the business. It points to improved returns and credit profile, load growth, upside capital spending tied to projects, a stable regulatory and political backdrop, and wildfire legislation. It lowered its estimates for fiscal 2027 through 2030 and raised them for fiscal 2031 and 2032 because of that spending. The target now uses 15.2 times fiscal 2029 peer earnings, up from 14.3 times.

Jefferies said shares are fairly valued at a 14% fiscal 2029 premium to peers. Possible catalysts include a 2032 request for proposals covering about 1 gigawatt of self-built gas generation and an 8.9% load forecast in its resource plan. BTIG kept a Buy rating and raised its target to $155 from $153, citing nearly 9% annual load growth over the next five years.

5. TIM (NYSE:TIMB)

Average Upside Potential: 15%

BofA Securities downgraded TIM to Neutral from Buy on November 17, a move it paired with a higher price target of R$24 from R$21. The call follows a rally in the stock. TIM shares are up 14% since Brazil’s elections, while the IBOV index fell 17% over the same period. Vivo, its main rival, rose 6%.

TIM provides mobile phone, internet and broadband services in Brazil. BofA said valuations now look balanced and largely reflect a better outlook for the sector, with TIM and Vivo trading at implied real equity internal rates of return of about 10% to 11%. It still calls TIM’s fundamentals compelling, with an 18% free cash flow yield. The gap between the two companies has narrowed. Vivo’s premium to TIM is back to about 10% on a free cash flow to equity yield basis, down from about 25% when BofA upgraded TIM to Buy.

BofA said Brazilian telecom investors have become more optimistic in recent weeks as companies signaled more rational pricing. TIM reported third-quarter 2026 results with growing broadband and business services and expanding margins.

4. PROG Holdings (NYSE:PRG)

Average Upside Potential: 20%

Loop Capital analyst Casey Coates downgraded PROG Holdings to Hold from Buy on November 17 and kept the price target at $40. Coates said the call is based on current valuation levels rather than a more bearish view of the company’s fundamentals. Loop Capital’s bullish outlook is largely priced in, and near-term risks include current macroeconomic conditions and the integration of Purchasing Power.

PROG Holdings provides lease-purchase solutions for furniture, home appliances and consumer electronics, mainly through its Progressive Leasing segment, with sales through franchised stores and an e-commerce platform. Coates said the firm’s fundamental view remains bullish. The company reported third-quarter 2026 revenue of $725.8 million, up about 26% from a year earlier. Non-GAAP diluted earnings per share were $1.06, up 21.8%, and consolidated gross merchandise volume rose 59%.

The call does not turn Loop Capital bearish on the business. It kept its target in place, which means the shares had already climbed to about where the firm thought they belonged. PROG trades at 7.36 times forward earnings, a low multiple that shows why bulls still see room in the stock.

3. CG Oncology (NASDAQ:CGON)

Average Upside Potential: 37%

RBC Capital downgraded CG Oncology to Sector Perform from Outperform on November 17 and raised its price target to $97 from $80. The move came the same day the company released data from its PIVOT-006 trial of cretostimogene, known as creto, in intermediate-risk bladder cancer. RBC said the data reinforced creto’s efficacy and safety and pointed to a bladder cancer market opportunity of more than $4.5 billion.

CG Oncology is a clinical-stage drug developer working on treatments that spare the bladder for patients with non-muscle invasive bladder cancer, and creto is its lead product in development. RBC still thinks creto may be best in class, but it cited several reasons for stepping back. The regulatory path may still be evolving, with possible delays and risk around chemistry, manufacturing and controls. RBC does not expect a commercial launch before 2028, and the field is getting more competitive each year.

RBC’s view is that the next catalyst for the shares may take time to arrive. RBC attributed the higher target to model updates, and the company has no approved product on the market yet.

2. Shoals Technologies Group (NASDAQ:SHLS)

Average Upside Potential: 59%

UBS downgraded Shoals Technologies Group to Neutral from Buy on November 17 and lowered its price target to $9 from $12. The new target comes from the merger Shoals announced on November 4 with Array Technologies. Shoals holders are expected to receive 1.6931 Array shares for each Shoals share, and UBS applied that ratio to its $5.50 target for Array.

Shoals makes electrical equipment for solar projects, battery storage sites and data centers, including homeruns and combiners. The all-stock merger is expected to close in the first quarter of 2027, subject to shareholder approval, and Shoals shareholders are expected to own about 65% of the company when it closes. Array will be the legal acquirer.

UBS called the merger a strategic positive overall for the company, though it creates some uncertainty around integration. The firm does not see the combined company as a finished product and expects more acquisitions into related product categories after the deal closes. In the third quarter of 2026, Shoals reported revenue of $195.3 million, up 44% from the previous year, and adjusted earnings of $0.14 per share.

1. Lucky Strike Entertainment (NYSE:LUCK)

Average Upside Potential: 84%

Truist Securities downgraded Lucky Strike Entertainment to Hold from Buy on November 17 and cut its price target to $4.35 from $8.00. The cut follows an offer from the company’s founder and chief executive officer to take it private at $4.35 per share, which the company disclosed on November 17. Truist assumes the deal is likely to go ahead, even if some investors object to the price.

Lucky Strike runs bowling centers with lounge seating, arcades and food and beverage service. Truist says sentiment on the stock has been weak even as store conversions stabilize and its other brands make progress. Investors remain cautious about when spending by middle-class and lower-income consumers will recover sustainably. In the first quarter of fiscal 2027, the company reported revenue of $303 million and adjusted EBITDA of $72 million.

Revenue grew 25.80% a year over the past five years but only 1.81% over the past 12 months. Operating margin over that period was 12.83%, while profit margin was -4.66%. The company reported those results on November 5. Truist’s Hold rating now reflects the offer price, with the new target set at that same $4.35.

READ NEXT: Jim Cramer Finds More Than a Stock Price Gap Between PepsiCo (PEP) and Coca-Cola (KO) and Jim Cramer Flags PepsiCo’s (PEP) Frito-Lay Problem While Pointing to Procter & Gamble (PG)

Follow Insider Monkey on Google News.